On October 24, 2018, the Eliminating Kickbacks in Recovery Act ("EKRA") was enacted. Broadly speaking, EKRA prohibits soliciting, receiving, paying, or offering "any remuneration.
The Eliminating Kickbacks in Recovery Act EKRA, 18 U.S.C. § 220, has caused confusion since its enactment in 2018. It prohibits the payment of remuneration in return for referring a patient to a recovery home, clinical treatment facility or laboratory.
The Eliminating Kickbacks in Recovery Act EKRA, 18 U.S.C. § 220, has caused confusion since its enactment in 2018. It prohibits the payment of remuneration in return for referring a patient to a recovery home, clinical treatment facility or laboratory.
Amniotic fluid injections appear to be at the center of the federal government’s most recent investigatory efforts into Medicare billing fraud; announced a flurry of investigations into practices that administer amniotic fluid injections as well as these services.